USGA yields 10000000.00% · JNJ yields 2.13%● Live data
📍 USGA pulled ahead of the other in Year 1
Combined, USGA + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of USGA + JNJ for your $10,000?
US Global Nanospace, Inc., a research and development company, is engaged in identifying, developing, and commercializing technologies and products for integration into the security, defense, and health and safety markets. It offers modular autonomous perimeter security and non-lethal defense system, an autonomous, intelligent, and integrated wide area perimeter security and denial system for large wide area perimeter applications, such as international and sovereign borders, oil and gas infrastructure, and other high value critical asset installations. The company also provides non-toxic decontaminant foam for the neutralization of chemical and biological weapons and contaminants; filter element materials; lightweight blast mitigation materials; castable blast mitigation products for munitions containers, munitions storage facilities, and other applications; and lightweight shielded turret for the high mobility multipurpose wheeled vehicles. In addition, it offers light weight anti-ballistic\blast fragment barrier materials; antiballistic replacement door skin products that are lightweight antiballistic panels designed to protect vehicle occupants in elevated-threat locations; cigarette filters; and radomes, a protective housing for radar antenna. It serves aerospace, homeland security, defense, transportation, construction, and industrial markets. US Global Nanospace, Inc. was founded in 2002 and is based in Carson City, Nevada.
Full USGA Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.